Darwin Wealth Management LLC Makes New Investment in The Clorox Company (NYSE:CLX)

Darwin Wealth Management LLC purchased a new position in shares of The Clorox Company (NYSE:CLX) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 450 shares of the company’s stock, valued at approximately $73,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Prospera Private Wealth LLC acquired a new position in Clorox during the 3rd quarter worth approximately $27,000. Innealta Capital LLC acquired a new position in shares of Clorox in the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC boosted its holdings in shares of Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares in the last quarter. Family Firm Inc. acquired a new position in shares of Clorox in the 2nd quarter valued at $31,000. Finally, Quarry LP boosted its holdings in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.57% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the subject of several research analyst reports. Citigroup upped their target price on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. DA Davidson upped their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Evercore ISI lowered their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Barclays upped their target price on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Five research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $155.00.

Clorox Price Performance

Shares of NYSE CLX opened at $168.05 on Thursday. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $169.21. The firm’s 50-day simple moving average is $162.64 and its 200 day simple moving average is $148.08. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The stock has a market cap of $20.80 billion, a P/E ratio of 58.55, a P/E/G ratio of 3.10 and a beta of 0.41.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the business earned $0.49 earnings per share. Clorox’s revenue for the quarter was up 27.0% compared to the same quarter last year. Equities analysts expect that The Clorox Company will post 6.85 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 2.90%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.